315 related articles for article (PubMed ID: 9229341)
21. Preparation, characterization and in vivo evaluation of ibuprofen binary solid dispersions with poloxamer 188.
Newa M; Bhandari KH; Li DX; Kwon TH; Kim JA; Yoo BK; Woo JS; Lyoo WS; Yong CS; Choi HG
Int J Pharm; 2007 Oct; 343(1-2):228-37. PubMed ID: 17597315
[TBL] [Abstract][Full Text] [Related]
22. New solid lipid microparticles for controlled ibuprofen release: formulation and characterization study.
Perge L; Robitzer M; Guillemot C; Devoisselle JM; Quignard F; Legrand P
Int J Pharm; 2012 Jan; 422(1-2):59-67. PubMed ID: 22027394
[TBL] [Abstract][Full Text] [Related]
23. ["Non-solvent shock agglomeration"--technology of a new alternative method for sustained release of ibuprofen. 5. Production and evaluation of retard formulations].
Möller T; Korsatko W
Pharmazie; 2000 Feb; 55(2):114-9. PubMed ID: 10723769
[TBL] [Abstract][Full Text] [Related]
24. Preliminary toxicokinetic study with different crystal forms of S (+)-ibuprofen (dexibuprofen) and R,S-ibuprofen in rats.
Walser S; Hruby R; Hesse E; Heinzl H; Mascher H
Arzneimittelforschung; 1997 Jun; 47(6):750-4. PubMed ID: 9239454
[TBL] [Abstract][Full Text] [Related]
25. Raman and thermal analysis of indomethacin/PVP solid dispersion enteric microparticles.
Fini A; Cavallari C; Ospitali F
Eur J Pharm Biopharm; 2008 Sep; 70(1):409-20. PubMed ID: 18621516
[TBL] [Abstract][Full Text] [Related]
26. Formulation studies on ibuprofen sodium-cationic dextran conjugate: effect on tableting and dissolution characteristics of ibuprofen.
Abioye AO; Kola-Mustapha A
Drug Dev Ind Pharm; 2016 Jan; 42(1):39-59. PubMed ID: 25826253
[TBL] [Abstract][Full Text] [Related]
27. Lipid nanocarriers as drug delivery system for ibuprofen in pain treatment.
Lamprecht A; Saumet JL; Roux J; Benoit JP
Int J Pharm; 2004 Jul; 278(2):407-14. PubMed ID: 15196644
[TBL] [Abstract][Full Text] [Related]
28. Development and evaluation of controlled-release diclofenac microspheres and tabletted microspheres.
Vilivalam VD; Adeyeye CM
J Microencapsul; 1994; 11(4):455-70. PubMed ID: 7931945
[TBL] [Abstract][Full Text] [Related]
29. Effect of manufacturing method on the in vitro drug release and adhesive performance of drug-in-adhesive films containing binary mixtures of ibuprofen with poloxamer 188.
Dodou K; Saddique W
Pharm Dev Technol; 2012; 17(5):552-61. PubMed ID: 21294623
[TBL] [Abstract][Full Text] [Related]
30. Enhancement of dissolution rate and bioavailability of aceclofenac: a chitosan-based solvent change approach.
Mutalik S; Anju P; Manoj K; Usha AN
Int J Pharm; 2008 Feb; 350(1-2):279-90. PubMed ID: 17945447
[TBL] [Abstract][Full Text] [Related]
31. Dissolution of ibuprofen from spray dried and spray chilled particles.
Elkordy AA; Essa EA
Pak J Pharm Sci; 2010 Jul; 23(3):284-90. PubMed ID: 20566441
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of a drug with wax-like properties as a melt binder.
Dhumal RS; Shimpi SL; Chauhan B; Mahadik KR; Paradkar A
Acta Pharm; 2006 Dec; 56(4):451-61. PubMed ID: 19839137
[TBL] [Abstract][Full Text] [Related]
33. Melt sonocrystallization of ibuprofen: effect on crystal properties.
Manish M; Harshal J; Anant P
Eur J Pharm Sci; 2005 May; 25(1):41-8. PubMed ID: 15854799
[TBL] [Abstract][Full Text] [Related]
34. A burst drug release caused by imperfection of polymeric film-coated microparticles prepared by a fluidized bed coater.
Sriamornsak P; Casallas-Hernández GL; Manchun S; Kumpugdee-Vollrath M
Pharmazie; 2011 Aug; 66(8):576-83. PubMed ID: 21901979
[TBL] [Abstract][Full Text] [Related]
35. Dissolution, bioavailability and ulcerogenic studies on piroxicam-nicotinamide solid dispersion formulations.
Verma MM; Kumar MT; Balasubramaniam J; Pandit JK
Boll Chim Farm; 2003 Apr; 142(3):119-24. PubMed ID: 12806831
[TBL] [Abstract][Full Text] [Related]
36. Influence of formulation variables on the in-vitro release of albumin from biodegradable microparticulate systems.
Igartua M; Hernández RM; Esquisabel A; Gascon AR; Calvo MB; Pedraz JL
J Microencapsul; 1997; 14(3):349-56. PubMed ID: 9147284
[TBL] [Abstract][Full Text] [Related]
37. Accelerated stability of Ibuprofen-Eudragit RSPM sustained release tablets, IR and DSC solid stability testing.
Abdel Rahman AA; Aboutaleb AE; Stamm A; Samy EM; Abdel-Rahman SI
J Pharm Belg; 1993; 48(6):463-70. PubMed ID: 8133428
[TBL] [Abstract][Full Text] [Related]
38. Effects of absorption rate on the pre-systemic chiral inversion of ibuprofen in rabbits.
Doki K; Hayakawa T; Lin W; Yanaguimoto H; Ding G; Inotsume N
J Pharm Pharmacol; 2003 Aug; 55(8):1091-7. PubMed ID: 12956898
[TBL] [Abstract][Full Text] [Related]
39. Design, characterization and in vitro evaluation of stavudine-loaded microspheres.
Vaghani SS; Sureja S; Singh S; Gurjar M; Jivani NP; Patel MM
Pharm Dev Technol; 2011 Apr; 16(2):146-51. PubMed ID: 20100058
[TBL] [Abstract][Full Text] [Related]
40. Determination of the physical state of drug in microcapsule and microsphere formulations.
Dash AK
J Microencapsul; 1997; 14(1):101-12. PubMed ID: 8994079
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
